Top Markets
Coin of the day
HLS Therapeutics Inc. HLS Therapeutics Inc.

HLS Therapeutics Inc.

HLS
株式のランク #22602
HLS Therapeutics Inc. operates as a specialized pharmaceutical firm,... HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.
株価
$2.75
最終同期: 2026-08-21
時価総額
$86.08M
変化(1日)
-3.85%
変化(1年)
-27.06%
CA
取引 HLS Therapeutics Inc. (HLS)

カテゴリー

HLS Therapeutics Inc.(HLS)の株価履歴
終値の最高値: $2.84 (2026-08-01)

終値の最安値: $8.95 (2018-03-01)
HLS Therapeutics Inc. の株価履歴(2018 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -2.35%
2025 38.06%
2024 -5.73%
2023 -63.25%
2022 -36.71%
2021 -13.17%
2020 -7.23%
2019 30.14%
2018 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$171.67 -
DE
$163.63 24.47%
DE
$37.61 20.44%
JP
$223.11 32.20%
CH
$20.99 11.67%
IN